BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31562358)

  • 1. Molecular phenotyping using networks, diffusion, and topology: soft tissue sarcoma.
    Mathews JC; Pouryahya M; Moosmüller C; Kevrekidis YG; Deasy JO; Tannenbaum A
    Sci Rep; 2019 Sep; 9(1):13982. PubMed ID: 31562358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.
    Nakayama R; Nemoto T; Takahashi H; Ohta T; Kawai A; Seki K; Yoshida T; Toyama Y; Ichikawa H; Hasegawa T
    Mod Pathol; 2007 Jul; 20(7):749-59. PubMed ID: 17464315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.
    Sioletic S; Czaplinski J; Hu L; Fletcher JA; Fletcher CD; Wagner AJ; Loda M; Demetri GD; Sicinska ET; Snyder EL
    J Pathol; 2014 Oct; 234(2):190-202. PubMed ID: 24852265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
    Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
    Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors.
    Skubitz KM; Pambuccian S; Manivel JC; Skubitz AP
    J Transl Med; 2008 May; 6():23. PubMed ID: 18460215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.
    Kim J; Kim JH; Kang HG; Park SY; Yu JY; Lee EY; Oh SE; Kim YH; Yun T; Park C; Cho SY; You HJ
    BMC Med Genet; 2018 Dec; 19(Suppl 1):216. PubMed ID: 30598078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
    Ryan CW; Desai J
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.
    Guijarro MV; Dahiya S; Danielson LS; Segura MF; Vales-Lara FM; Menendez S; Popiolek D; Mittal K; Wei JJ; Zavadil J; Cordon-Cardo C; Pandolfi PP; Hernando E
    Am J Pathol; 2013 Jun; 182(6):2015-27. PubMed ID: 23708211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 in bone and soft tissue sarcomas.
    Thoenen E; Curl A; Iwakuma T
    Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soft tissue sarcomas: From a morphological to a molecular biological approach.
    Oda Y; Yamamoto H; Kohashi K; Yamada Y; Iura K; Ishii T; Maekawa A; Bekki H
    Pathol Int; 2017 Sep; 67(9):435-446. PubMed ID: 28759137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.
    West RB
    Adv Anat Pathol; 2010 Sep; 17(5):366-73. PubMed ID: 20733355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
    Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
    J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.
    Yu PY; Balkhi MY; Ladner KJ; Alder H; Yu L; Mo X; Kraybill WG; Guttridge DC; Iwenofu OH
    Lab Invest; 2016 Apr; 96(4):481-91. PubMed ID: 26878133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA hypermethylation status of multiple genes in soft tissue sarcomas.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Takahira T; Kobayashi C; Tamiya S; Tateishi N; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2006 Jan; 19(1):106-14. PubMed ID: 16258501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
    van IJzendoorn DGP; Szuhai K; Briaire-de Bruijn IH; Kostine M; Kuijjer ML; Bovée JVMG
    PLoS Comput Biol; 2019 Feb; 15(2):e1006826. PubMed ID: 30785874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma.
    Liu W; Tong H; Zhang C; Zhuang R; Guo H; Lv C; Yang H; Lin Q; Guo X; Wang Z; Wang Y; Shen F; Wang S; Dai C; Wang G; Liu J; Lu W; Zhang Y; Zhou Y
    BMC Cancer; 2020 Oct; 20(1):1035. PubMed ID: 33115433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
    Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
    Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics.
    Gibault L; Pérot G; Chibon F; Bonnin S; Lagarde P; Terrier P; Coindre JM; Aurias A
    J Pathol; 2011 Jan; 223(1):64-71. PubMed ID: 21125665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.